Erika Bonacina

18PUBLICATIONS
68CO-AUTHORS
Infant and child healthPsychosocial aspects of childbirth and perinatal mental healthNeonatologyPredictive and prognostic markersFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Mar 30, 2026
Placental insufficiency markers to assess the risk of non-chromosomal genetic conditions in early-onset fetal growth restriction.

M Armengol-Alsina, E Bonacina, M Dalmau

|Jan 03, 2026
Cost-benefit analysis of first-trimester pre-eclampsia screening: comparison of multivariable Gaussian algorithm with and without placental growth factor.

E Bonacina, M Armengol-Alsina, M Dalmau

|Sep 29, 2025
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised Trial.

Erika Bonacina, Mireia Armengol-Alsina, Pablo Garcia-Manau

|Jan 08, 2025
Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.

Pablo Garcia-Manau, Erika Bonacina, Raquel Martin-Alonso

|Dec 06, 2024
Role of routine uterine artery Doppler at 18-22 and 24-28 weeks' gestation following routine first-trimester screening for pre-eclampsia.

E Bonacina, E Del Barco, A Farràs

|Aug 22, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trial.

Marta Ricart, Erika Bonacina, Pablo Garcia-Manau

Pageof 3